Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
11/2003
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6638969 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638525 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199559 Process for making amlodipine maleate
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/22/2003EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it
10/22/2003EP1354604A1 Combinations for cardiovascular indications
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/15/2003EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein
10/15/2003CN1449395A Process for preparing azacycloalkanoyl aminothiazoles
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003US20030191337 Crystal of bicalutamide and production method thereof
10/09/2003US20030190314 Administering spray dried plasma for modulating immunoglobulin levels; vaccines; for weight gain; autoimmune disorders
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447694A Rapid onset formulation
10/07/2003US6630514 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003018031A3 Single dose azithromycin for treating respiratory infections
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
09/2003
09/25/2003WO2002024690A3 Efficient process for the preparation of a factor xa inhibitor
09/24/2003EP1345942A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/18/2003WO2003075914A1 Citalopram for the treatment of elevated blood pressure
09/18/2003WO2003045392A3 Use of n-(indolcarbonyl-)piperazine derivatives
09/18/2003WO2003024489A3 Combination of a nsaid and a pde-4 inhibitor
09/18/2003CA2459834A1 Citalopram for the treatment of elevated blood pressure
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP0768089B1 Hot water extract of Cordyceps sinensis
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/12/2003WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics
09/12/2003CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics
09/10/2003EP1156814B1 Pharmaceuticals, dietary supplements and cosmetic compositions comprising a fatty acid and ginger
09/10/2003EP1137644B1 Benzofuran derivatives, their preparation and use
09/09/2003US6617332 Cyclic amidinourea derivatives
09/04/2003WO2003072576A2 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003US20030166935 Spiroazabicyclic heterocyclic compounds
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166631 Pharmaceutical compositions and methods for administering EP2 receptor selective agonists
09/04/2003US20030166617 Combination therapies with vascular damaging activity
09/04/2003US20030165496 Alzheimer's disease
09/04/2003CA2477379A1 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/03/2003EP1140187B1 Combinations of an ibat inhibitor and a mtp inhibitor for cardiovascular indications
08/2003
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070246A1 Controlled synthesis of ziprasidone and compositions thereof
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030161867 Skin-permeable selective cyclooxygenase-2 inhibitor composition
08/28/2003US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/26/2003US6610332 Antiprotozoa agents; plant extracts
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/20/2003EP1336413A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
08/20/2003CN1118571C Active protein with thrombopoietin
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
08/14/2003US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030148964 Single dose azithromycin
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 32